These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 18337833)

  • 41. CDKN2A and MC1R analysis in amelanotic and pigmented melanoma.
    Ghiorzo P; Pastorino L; Pizzichetta MA; Bono R; Queirolo P; Talamini R; Annessi G; Bruno W; Nasti S; Gargiulo S; Battistuzzi L; Sini MC; Palmieri G; Scarrà GB;
    Melanoma Res; 2009 Jun; 19(3):142-5. PubMed ID: 19339902
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of p16 immunohistochemical stain to help differentiate inflamed melanocytic nevi from metastatic melanoma in the setting of immunotherapy.
    Adelman M; Lyons AB; Seale L; Friedman BJ
    J Am Acad Dermatol; 2020 Apr; 82(4):e117-e119. PubMed ID: 31765681
    [No Abstract]   [Full Text] [Related]  

  • 43. A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs.
    Zhu G; Duffy DL; Eldridge A; Grace M; Mayne C; O'Gorman L; Aitken JF; Neale MC; Hayward NK; Green AC; Martin NG
    Am J Hum Genet; 1999 Aug; 65(2):483-92. PubMed ID: 10417291
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Malignant melanoma arising from an NRAS-mutated medium-sized congenital melanocytic nevus.
    Kiyohara T; Takata M; Itoh H; Kawami K; Ido H; Ishida H; Kumakiri M
    J Dermatol; 2012 Dec; 39(12):1034-5. PubMed ID: 22452623
    [No Abstract]   [Full Text] [Related]  

  • 45. [Family studies on the incidence of multiple pigmented naevi, familial skin melanoma and other malignant tumors].
    Szekeres L; Korom I
    Orv Hetil; 1991 Sep; 132(39):2153-6. PubMed ID: 1923488
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The genetics of hereditary melanoma and nevi. 1998 update.
    Greene MH
    Cancer; 1999 Dec; 86(11 Suppl):2464-77. PubMed ID: 10630172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CDKN2A/CDK4 molecular study on 155 Italian subjects with familial and/or primary multiple melanoma.
    Majore S; De Simone P; Crisi A; Eibenschutz L; Binni F; Antigoni I; De Bernardo C; Catricalà C; Grammatico P
    Pigment Cell Melanoma Res; 2008 Apr; 21(2):209-11. PubMed ID: 18363633
    [No Abstract]   [Full Text] [Related]  

  • 48. Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patients.
    Ghiorzo P; Villaggio B; Sementa AR; Hansson J; Platz A; Nicoló G; Spina B; Canepa M; Palmer JM; Hayward NK; Bianchi-Scarrà G
    Hum Pathol; 2004 Jan; 35(1):25-33. PubMed ID: 14745721
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The familial occurrence of cutaneous melanoma, intraocular melanoma, and the dysplastic nevus syndrome.
    Greene MH; Sanders RJ; Chu FC; Clark WH; Elder DE; Cogan DG
    Am J Ophthalmol; 1983 Aug; 96(2):238-45. PubMed ID: 6881247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families.
    Taylor NJ; Handorf EA; Mitra N; Avril MF; Azizi E; Bergman W; Bianchi-Scarrà G; Bishop DT; Bressac-de Paillerets B; Calista D; Cannon-Albright LA; Cuellar F; Cust AE; Demenais F; Elder DE; Friedman E; Gerdes AM; Ghiorzo P; Goldstein AM; Grazziotin TC; Hansson J; Hayward NK; Hocevar M; Höiom V; Holland EA; Ingvar C; Landi MT; Landman G; Larre-Borges A; Leachman SA; Mann GJ; Nagore E; Olsson H; Palmer J; Perić B; Pjanova D; Puig S; Schmid H; van der Stoep N; Tucker MA; Wadt KAW; Whitaker L; Yang XR; Newton Bishop JA; Gruis NA; Kanetsky PA;
    J Invest Dermatol; 2016 May; 136(5):1066-1069. PubMed ID: 26827760
    [No Abstract]   [Full Text] [Related]  

  • 51. CDKN2A: the IVS2-105A/G intronic mutation found in an Italian patient affected by eight primary melanomas.
    Majore S; Catricalà C; Binni F; De Simone P; Eibenschutz L; Grammatico P
    J Invest Dermatol; 2004 Feb; 122(2):450-1. PubMed ID: 15009729
    [No Abstract]   [Full Text] [Related]  

  • 52. MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.
    Fargnoli MC; Gandini S; Peris K; Maisonneuve P; Raimondi S
    Eur J Cancer; 2010 May; 46(8):1413-20. PubMed ID: 20189796
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pancreatic carcinoma surveillance in patients with familial melanoma.
    Parker JF; Florell SR; Alexander A; DiSario JA; Shami PJ; Leachman SA
    Arch Dermatol; 2003 Aug; 139(8):1019-25. PubMed ID: 12925390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool.
    Bauer J; Bastian BC
    Dermatol Ther; 2006; 19(1):40-9. PubMed ID: 16405569
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical germline genetic testing for melanoma.
    Hansen CB; Wadge LM; Lowstuter K; Boucher K; Leachman SA
    Lancet Oncol; 2004 May; 5(5):314-9. PubMed ID: 15120668
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas.
    Bastian BC; Xiong J; Frieden IJ; Williams ML; Chou P; Busam K; Pinkel D; LeBoit PE
    Am J Pathol; 2002 Oct; 161(4):1163-9. PubMed ID: 12368190
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gene expression signature as an ancillary method in the diagnosis of desmoplastic melanoma.
    Clarke LE; Pimentel JD; Zalaznick H; Wang L; Busam KJ
    Hum Pathol; 2017 Dec; 70():113-120. PubMed ID: 29079183
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CDKN2A/p16 genetic test reporting improves early detection intentions and practices in high-risk melanoma families.
    Aspinwall LG; Leaf SL; Dola ER; Kohlmann W; Leachman SA
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1510-9. PubMed ID: 18559569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma.
    Liu L; Dilworth D; Gao L; Monzon J; Summers A; Lassam N; Hogg D
    Nat Genet; 1999 Jan; 21(1):128-32. PubMed ID: 9916806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BRAFV600E mutation in oral melanocytic nevus and oral mucosal melanoma.
    Resende TAC; de Andrade BAB; Bernardes VF; Coura BP; Delgado-Azãnero W; Mosqueda-Taylor A; de Almeida OP; Gomes CC; Gomez RS
    Oral Oncol; 2021 Mar; 114():105053. PubMed ID: 33189579
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.